Yep...Everyone should go read about it's data compared to Tempol.....
and see what NIH thought of it last year even though they continue with it.
To say it is a competitor based on "Known" results from small studies,nothing has a safety profile compared to ADMP's Tempol with 2300 publications..How many does Merk's drug have??..*lol...
Thanks for the comparison found...Tic Toc Roll......